Product Information

Tazemetostat is a methyltransferase inhibitor used to treat metastatic or locally advanced epithelioid sarcoma that cannot be completely resected.

Tazemetostat

CAS No.	1403254-99-8
MDL No.	N/A
MF	C₃₄H₄₄N₄O₄
MW	572.70
InChI Key	NSQSAUGJQHDYNO-UHFFFAOYSA-N

Pack Size	Purity	Price	Availability	Action
-	-	On Request	On Request
Custom synthesis and bulk supply options are available upon request.

Tazemetostat is a methyltransferase inhibitor used to treat metastatic or locally advanced epithelioid sarcoma that cannot be completely resected.